You are here

Article info

Article menu
Download PDFPDF
Editorial commentary
Natalizumab in clinical practice: managing the risks, enjoying the benefits

Authors

  1. Correspondence to Professor Orhan Aktas, Department of Neurology, Heinrich-Heine-University, Moorenstr. 5, Düsseldorf D-40225, Germany; orhan.aktas{at}hhu.de
View Full Text

Citation

Aktas O
Natalizumab in clinical practice: managing the risks, enjoying the benefits
Journal of Neurology, Neurosurgery & Psychiatry 2014;85:1181.

Publication history

  • Received March 2, 2014
  • Accepted March 4, 2014
  • First published March 21, 2014.
Online issue publication 
October 17, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions